Check how courts have cited this case. Use our free citator for the most current treatment.
No. 9951150
United States Court of Appeals for the Ninth Circuit
Iran Thalassemia Society v. Office of Foreign Assets Control
No. 9951150 · Decided June 27, 2024
No. 9951150·Ninth Circuit · 2024·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
June 27, 2024
Citation
No. 9951150
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS JUN 27 2024
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
IRAN THALASSEMIA SOCIETY, an NGO No. 23-35366
with over 23,000 thalassemia member
patients; H.K., a five-year-old male Iranian D.C. No. 3:22-cv-01195-HZ
child suffering from epidermolysis bullosa;
A.M., a similarly afflicted seven year old
female Iranian child; S.N., a similarly MEMORANDUM*
afflicted ten year old male Iranian child;
M.M., a similarly afflicted thirteen year old
female Iranian child; FZ.H., a similarly
afflicted eighteen year old female Iranian
youth; F.E., a similarly afflicted twenty one
year old female Iranian youth; NO CHILD
SHOULD SUFFER, an Oregon domestic
nonprofit corporation; EB HOME, an NGO
with over 500 registered epidermolysis
bullosa patients,
Plaintiffs-Appellants,
v.
OFFICE OF FOREIGN ASSETS
CONTROL; JANET YELLEN, Secretary of
the Treasury; ANDREA GACKI, Director of
the Office of Foreign Assets Control,
Defendants-Appellees.
Appeal from the United States District Court
for the District of Oregon
*
This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
Marco A. Hernandez, Chief District Judge, Presiding
Argued and Submitted May 13, 2024
San Francisco, California
Before: CALLAHAN and NGUYEN, Circuit Judges, and KRONSTADT,**
District Judge.
Plaintiffs are a group of Iranian citizens suffering from rare genetic
disorders, Iranian organizations representing such individuals, and No Child
Should Suffer, an Oregon non-profit corporation that is seeking to donate funds for
the treatment of those disorders. Plaintiffs seek medical treatment consisting of
iron-chelating drugs to complement blood transfusion therapy, and a specific type
of wound dressing. In this action, Plaintiffs seek an injunction and declaration that
the Office of Foreign Assets Control (“OFAC”) has violated the law by threatening
to impose sanctions on transactions involving humanitarian aid to Iran. The
district court granted, without leave to amend, Defendants-Appellees’ motion to
dismiss the Second Amended Complaint (“SAC”) for lack of standing.
We have jurisdiction under 28 U.S.C. § 1291. We review de novo a district
court’s order granting a motion to dismiss for lack of jurisdiction. Chen v. Allstate
Ins. Co., 819 F.3d 1136, 1141 (9th Cir. 2016). We review for abuse of discretion a
district court’s refusal to grant leave to amend when a motion to dismiss is granted.
**
The Honorable John A. Kronstadt, United States District Judge for the
Central District of California, sitting by designation.
2
Hoang v. Bank of America, N.A., 910 F.3d 1096, 1102 (9th Cir. 2018). We affirm.
1. Article III standing requires that the plaintiffs show (1) that they have
suffered an injury in fact (2) which is fairly traceable to the defendant’s challenged
conduct, and (3) that their injury is likely to be redressed by a favorable decision.
Lujan v. Defenders of Wildlife, 504 U.S. 555, 560–61 (1992). Where, as here, the
plaintiffs’ theory of standing rests upon the independent choices of third parties not
before the court, “it becomes the burden of the plaintiff to adduce facts showing
that those choices have been or will be made in such a manner as to produce
causation and permit redressability of injury.” Id. at 562. “That’s so because the
third parties may well have engaged in their injury-inflicting actions even in the
absence of the government’s challenged conduct.” Mendia v. Garcia, 768 F.3d
1009, 1013 (9th Cir. 2014). There is no redressability where “any prospective
benefits depend on an independent actor who retains broad and legitimate
discretion” to decline to take the action which would redress the injury. Glanton
ex rel. ALCOA v. AdvancePCS Inc., 465 F.3d 1123, 1125 (9th Cir. 2006).
Plaintiffs have pleaded facts that, if established, would show that prior to
2018, the drugs and wound dressings used to treat the relevant medical conditions
flowed into Iran without limitation. However, with the beginning of the
“maximum pressure” sanctions regime in 2018, Plaintiffs have been unable to
arrange the purchase or delivery of the necessary medical supplies. Specifically,
3
Plaintiffs contend that the needed supplies became unavailable after OFAC issued
public statements that transactions for humanitarian goods, including the relevant
medicines and dressings, were subject to sanctions if they involved certain
Specially Designated Nationals (“SDNs”). The SAC alleges that because of
OFAC’s threats to impose sanctions, third party banks refused to facilitate
transactions between sellers and manufacturers of pharmaceutical products and
their Iranian counterparties. The SAC also alleges that, as a result of OFAC’s
threats, the pharmaceutical company that manufactures the necessary wound
dressings refused to do any business involving Iran. Thus, the SAC alleges that
Plaintiffs were harmed by OFAC’s statements because they have made it
extraordinarily difficult, if not impossible, to obtain the relevant drugs and
dressings within Iran.
Plaintiffs have not pleaded facts sufficient to establish causation. Plaintiffs’
theory of causation hinges upon third parties’ subjective fears of future government
action. As the Supreme Court clarified in Clapper v. Amnesty Int’l USA, 568 U.S.
398 (2013), third parties’ refusal to engage with plaintiffs based on their subjective
fears of future government action does not establish that any injuries to those
plaintiffs are fairly traceable to the challenged government actions. Clapper, 568
U.S. at 417–18, 417 n.7. Accordingly, there is no causation under the set of facts
4
alleged by Plaintiffs.1
Plaintiffs have not pleaded facts sufficient to establish redressability. As
noted, there is no redressability if, following a favorable decision, redress of the
injury “would still depend on the unfettered choices made by independent actors
not before the courts.” Novak v. United States, 795 F.3d 1012, 1020 (9th Cir.
2015) (citing ASARCO Inc. v. Kadish, 490 U.S. 605, 615 (1989)). The SAC
alleges that, following the 2018 “maximum pressure” sanctions, third party banks
withdrew from the Iranian market due both to “fears of sanctions” as well as
“minimal” fees. See Novak, 795 F.3d at 1020 (stating that there is no redressability
where plaintiffs have “alleged several reasons” that their injury may persist even if
relief were granted). The SAC also alleges that the manufacturer of the wound
dressings has declined to transact with Iranian counterparties even under any of
several exemptions to the U.S. sanctions regime. Given these allegations, any
judicially-ordered relief would leave the third party banks and pharmaceutical
company free to continue to decline to do business in, or with those in Iran. Thus,
there is no redressability.
1
Certain plaintiffs contend that a letter from the pharmaceutical company that
manufactures the needed wound dressings demonstrates that the pharmaceutical
company’s refusal to deal with Iranian counterparties is caused by OFAC’s
threatened sanctions. However, this letter states that the company is not willing to
sell its products to Iran because of “US Economic sanctions in force,” not OFAC’s
public statements concerning the scope of humanitarian exemptions to Iranian
sanctions. Therefore, the letter does not demonstrate causation.
5
Finally, No Child Should Suffer lacks standing because it has neither
articulated a concrete plan to donate funds nor been subject to a specific warning
or threat of enforcement. Thus, there is no case or controversy with respect to No
Child Should Suffer. Sacks v. OFAC, 466 F.3d 764, 772 (9th Cir. 2006); Wolfson
v. Brammer, 616 F.3d 1045, 1058 (9th Cir. 2010).
Because Plaintiffs cannot show causation or redressability, they have not
established Article III standing.
2. The district court did not abuse its discretion when it declined to grant
Plaintiffs leave to amend their Complaint a third time. Plaintiffs’ theory relies
upon an assumption that the injunctive and declaratory relief that they seek would
make it substantially more likely that counterparties would resume business with
those in Iran. In seeking leave to amend the SAC, Plaintiffs have not stated what
facts they may add to the SAC to correct deficiencies concerning causation and
redressability. Foman v. Davis, 371 U.S. 178, 182 (1962) (leave to amend may be
denied due to “futility of amendment”). Because these deficiencies would persist
notwithstanding any amendment, we conclude that amendment would be futile and
affirm.
AFFIRMED.
6
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUN 27 2024 MOLLY C.
Key Points
01NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUN 27 2024 MOLLY C.
02COURT OF APPEALS FOR THE NINTH CIRCUIT IRAN THALASSEMIA SOCIETY, an NGO No.
0323-35366 with over 23,000 thalassemia member patients; H.K., a five-year-old male Iranian D.C.
043:22-cv-01195-HZ child suffering from epidermolysis bullosa; A.M., a similarly afflicted seven year old female Iranian child; S.N., a similarly MEMORANDUM* afflicted ten year old male Iranian child; M.M., a similarly afflicted thirteen year
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUN 27 2024 MOLLY C.
FlawCheck shows no negative treatment for Iran Thalassemia Society v. Office of Foreign Assets Control in the current circuit citation data.
This case was decided on June 27, 2024.
Use the citation No. 9951150 and verify it against the official reporter before filing.